If you have been reading about research chemical and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-19. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Peppermint (Mentha × piperita) is a hybrid species of mint, a cross between watermint and spearmint. Indigenous to Europe and the Middle East, the plant is now widely spread and cultivated in many regions of the world. It is occasionally found in the wild with its parent species. Although the genus Mentha comprises more than 25 species, peppermint is the most widely used variant. While Western peppermint is derived from Mentha × piperita, Chinese peppermint, or bohe, is derived from the fresh leaves of M. haplocalyx. M. × piperita and M. haplocalyx are both recognised as plant sources of menthol and menthone, and are among the oldest herbs used for both culinary and medicinal products.
== Procedure == The test uses a single fasting blood sample, typically collected in a tube such as an NMR LipoTube or a standard red-top tube, and is processed by commercial laboratories. It's often part of a broader NMR LipoProfile, which also assesses cardiovascular risk through lipoprotein particle numbers (e.g., LDL-P).
==== Other ==== People taking zinc supplements may slow down the progress to age-related macular degeneration. Zinc supplement is an effective treatment for acrodermatitis enteropathica, a genetic disorder affecting zinc absorption that was previously fatal to affected infants. Zinc deficiency has been associated with major depressive disorder (MDD), and zinc supplements may be an effective treatment. Zinc may help individuals sleep more.
==== Rivaroxaban ==== Rivaroxaban chemically belongs to the group of n-aryloxazolidinones. Other drugs of that group are linezolid and tedizolid, both of whom are antibiotics. A synthesis of n-aryloxazolidinones starting with an O-silyl protected ethyl(2,3-dihydroxypropyl)-carbamate was published in 2016. In a one-pot reaction the carbamate cyclisizes to a 2-oxazolidone ring under slightly basic conditions while simultaneously the oxazolidone nitrogen is arylized by copper-catalization. For rivaroxaban in particular, 3-morpholinone substitutes the iodine in p-position of the benzene ring by copper-catalization. Afterwards, the silyl protecting group is removed and the resulting alcohol is replaced by an amino group which is then acylated in the last step. An industrial preparation of rivaroxaban was registered as a patent by Bayer Healthcare in 2005. It starts from N-(4-aminophenol)-morpholinone which is alkylated by a propylene oxide derivate that also contains a primary amine involved in a phthalimide protection group. Next, a phosgene equivalent is added to form the 2-oxazolidone ring and the phthalimide is removed. The free amine can now be acylated which leads to rivaroxaban. However, according to the patent the synthesis has “various disadvantages in the reaction management which has particularly unfavourable effects for preparation“. The patent also explains another synthesis starting from a chlorothiophene derivate that would be more suitable for the industrial process but points out that toxic solvents or reagents have to be removed from the final product.
Sources: en.wikipedia.org
Further investigations showed that the babies had not been injected with the potassium via IV method, but instead, that they had received the injections in their backs and with clothes on while they were in the resuscitation room. On the same day that police announced the arrest of nurse Brenda Agüero, the minister of health of Córdoba, Diego Cardozo, resigned from his position after heavy criticism for his handling of the case. Cardozo said that he had presented his resignation with the goal of helping clarify and serve justice in the case. Governor Juan Schiaretti assigned the ministry to María Gabriela Barbás. In February 2023, the head of the hospital, 70-year-old Liliana Asís, was arrested and accused of concealing the unnatural deaths of the babies from the authorities. She was granted house arrest in May 2023 due to her deteriorating health while in prison. Along with Asís, more officials and local politicians were indicted for either concealment or wrongdoing.
In 1985, the FDA further required a boxed warning to be added, but the problem grew with an estimated 1000 birth defects attributed to the drug by early 1988. While an advisory committee of pediatricians and Centers for Disease Control and Prevention (CDC) staff advised the FDA to restrict Accutane prescriptions, the FDA instead required Roche to expand its warnings of potential side effects and provide informed consent forms to doctors. In 2000, the CDC reported that Roche's Pregnancy Prevention Program of providing contraception counseling and pregnancy testing for women prescribed Accutane was ineffective. The revamped "Targeted Pregnancy Prevention Program" advised women to use two kinds of contraceptives and two pregnancy tests while requiring doctors to directly provide prescriptions to pharmacists to limit off-label use. After Representative Bart Stupak's son committed suicide while taking Accutane in May 2000, Congress held hearings in which some dermatologists attested to Accutane's efficacy in reducing acne and its associated stigma, while others petitioned the FDA for further restrictions of its use. In 2001, the FDA announced the System to Manage Accutane Related Teratogenicity (SMART), which required Roche to train doctors for a sticker-based system of verifying that female patients took pregnancy tests before using Accutane. SMART was replaced by the iPLEDGE program in March 2006. In February 2002, Roche's patents for isotretinoin expired, allowing generic drugs to enter the market.
=== Protein === Protein HtrA2, also known as Omi, is a mitochondrially-located serine protease. The human protein Serine protease HTRA2, mitochondrial is 49kDa in size and composed of 458 amino acids. The peptide fragment of 1-31 amino acid is the mitochondrial transition sequence, fragment 32-133 amino acid is propertied, and 134-458 is the mature protein Serine protease HTRA2, mitochondrial, and its theoretical pI of this protein is 6.12. HtrA2 shows similarities with DegS, a bacterial protease present in the periplasm of gram-negative bacteria. Structurally, HtrA2 is a trimeric molecule with central protease domains and a carboxy-terminal PDZ domain, which is characteristic of the HtrA family. The PDZ domain preferentially binds C-terminus of the protein substrate and modulate the proteolytic activity of the trypsin-like protease domain.
== Early life, education and career == Roy was born in the Indian state of West Bengal. He completed his schooling at Ballygunge Government High School, then obtained a first class honours degree in chemistry (BSc Hons) from Presidency College, Calcutta in 1974 and did his doctoral studies at the University of Delaware under the guidance of Prof. Roberta F. Colman to secure a PhD in 1981. His post-doctoral studies were at Brandeis University at the laboratory of Prof. Alfred Redfield (1981–82) and at the National Institutes of Health (1982–86). Returning to India in 1986, he joined Bose Institute, Kolkata as a senior lecturer in the department of biophysics. He served the Institute till 2004 holding positions of Reader and then Professor of Biophysics when he moved to the Indian Institute of Chemical Biology (IICB) as its director. After completing 10 years as the director of IICB, he returned to Bose Institute in 2014 as a senior professor and dean of studies. While at IICB, he has served the nation in several different high-level capacities such as the founder-director-in-charge of the National Institute of Pharmaceutical Education and Research, Kolkata (NIPER) (2007–14), the cluster director of 11 Biological institutes of the Council of Scientific and Industrial Research (CSIR) (2009–14), member of the governing body of the CSIR and as a visiting professor at Osaka University (2012). He has served as the president of the West Bengal Academy of Science and Technology. He is the founder-president of the Chemical Biology Society of India.
With the dissolution of the Napoleonic Kingdom of Italy in 1814, following the final fall of Emperor Napoleon I after the Battle of Waterloo, Ferdinand's son, Francis IV, assumed the rule as Duke of Modena. In December 1815 he obtained the transfer from his mother Maria Beatrice d'Este of the former imperial fiefs in Lunigiana, not reconstituted by the Congress of Vienna and bestowed upon her. On her death in 1829, he also inherited the Duchy of Massa and Carrara, which she had in turn received from her mother Maria Teresa Cybo-Malaspina, since Salic Law was derogated there by special imperial investiture. In the course of the Italian unification period in the 1830s-60s, the "Austria-Este" dukes were briefly ousted in the revolutions of 1831 and 1848, but soon returned. During the Second Italian War of Independence (April to July 1859) following the Battle of Magenta, the last Duke Francis V was again forced to flee, this time permanently. In December, Modena joined with Tuscany and Parma to form the "United Provinces of Central Italy", which were annexed to the growing Kingdom of Sardinia in March 1860, which led the Italian unification movement, which further led to the proclamation of the Kingdom of Italy in 1861.
Sources: en.wikipedia.org
After the Indo-Pakistani war of 1947–1948, three distinct areas of the princely state of Jammu and Kashmir were under Indian control: Muslim-majority Kashmir Valley, Hindu-majority Jammu region, and Buddhist-dominated Ladakh district. These regions were constituted as Jammu and Kashmir state and accorded special status by Article 370 of the Constitution of India, adopted in 1950. In contrast to other states of India, Jammu and Kashmir established its own constitution, flag, and administrative autonomy. In 1954, Article 35A was introduced via a Presidential Order under Article 370, empowering the Jammu and Kashmir Legislature to define permanent residents and bar Indian citizens from other states from purchasing property. From the early 1950s, Jammu and Kashmir used the titles of Prime Minister and Sadr-e-Riyasat for its executive heads, as permitted under Article 370 and formalised in the Delhi Agreement of 1952. The Constituent Assembly, tasked with drafting the constitution and deciding Article 370's future, adopted the constitution of Jammu and Kashmir in 1957 and then dissolved without recommending 370's abrogation, leading to the provision's indefinite continuation. In 1953, Sheikh Abdullah, the first Prime Minister of Jammu and Kashmir, was dismissed and jailed by the Indian government over charges of conspiracy, accused of espousing the creation of an independent country.
=== Over-reporting by China === China overwhelmingly dominates the world in reported aquaculture output, reporting a total output which is double that of the rest of the world put together. However, there are some historical issues with the accuracy of China's returns. In 2001, scientists Reg Watson and Daniel Pauly expressed concerns that China was over reporting its catch from wild fisheries in the 1990s. They said that made it appear that the global catch since 1988 was increasing annually by 300,000 tonnes, whereas it was really shrinking annually by 350,000 tonnes. Watson and Pauly suggested this may have been related to Chinese policies where state entities that monitored the economy were also tasked with increasing output. Also, until more recently, the promotion of Chinese officials was based on production increases from their own areas. China disputed this claim. The official Xinhua News Agency quoted Yang Jian, director general of the Agriculture Ministry's Bureau of Fisheries, as saying that China's figures were "basically correct". However, the FAO accepted there were issues with the reliability of China's statistical returns, and for a period treated data from China, including the aquaculture data, apart from the rest of the world.
The Napoleonic wars also played a key role in the independence of the Latin American colonies from Spain and Portugal. The conflict weakened the authority and military power of Spain, especially after the Battle of Trafalgar. There were many uprisings in Spanish America, leading to the wars of independence. In Portuguese America, Brazil experienced greater autonomy as it now served as seat of the Portuguese Empire and ascended politically to the status of Kingdom. These events also contributed to the Portuguese Liberal Revolution in 1820 and the Independence of Brazil in 1822. The century of relative transatlantic peace, after the Congress of Vienna, enabled the "greatest intercontinental migration in human history" beginning with "a big spurt of immigration after the release of the dam erected by the Napoleonic Wars." Immigration inflows relative to the US population rose to record levels (peaking at 1.6 percent in 1850–1851), as 30 million Europeans relocated to the United States between 1815 and 1914. Another concept emerged from the Congress of Vienna—that of a unified Europe. After his defeat, Napoleon deplored the fact that his dream of a free and peaceful "European association" remained unaccomplished. Such a European association would share the same principles of government, system of measurement, currency and Civil Code. One-and-a-half centuries later, and after two world wars several of these ideals re-emerged in the form of the European Union.
Electronegativity is a chemical property that describes the tendency of an atom or a functional group to attract electrons (or electron density) towards itself. If the bond between sodium and chlorine in sodium chloride were covalent, the pair of shared electrons would be attracted to the chlorine because the effective nuclear charge on the outer electrons is +7 in chlorine but is only +1 in sodium. The electron pair is attracted so close to the chlorine atom that they are practically transferred to the chlorine atom (an ionic bond). However, if the sodium atom was replaced by a lithium atom, the electrons will not be attracted as close to the chlorine atom as before because the lithium atom is smaller, making the electron pair more strongly attracted to the closer effective nuclear charge from lithium. Hence, the larger alkali metal atoms (further down the group) will be less electronegative as the bonding pair is less strongly attracted towards them. As mentioned previously, francium is expected to be an exception. Because of the higher electronegativity of lithium, some of its compounds have a more covalent character. For example, lithium iodide (LiI) will dissolve in organic solvents, a property of most covalent compounds. Lithium fluoride (LiF) is the only alkali halide that is not soluble in water, and lithium hydroxide (LiOH) is the only alkali metal hydroxide that is not deliquescent.
=== In-line check valve === An in-line check valve is a check valve similar to the lift check valve. However, this valve generally has a spring that will 'lift' when there is pressure on the upstream side of the valve. The pressure needed on the upstream side of the valve to overcome the spring tension is called the 'cracking pressure'. When the pressure going through the valve goes below the cracking pressure, the spring will close the valve to prevent back-flow in the process.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.